nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Pethidine—GRIN2A—melanoma	0.0192	0.67	CrCbGaD
Milnacipran—Dysgeusia—Vemurafenib—melanoma	0.00694	0.00714	CcSEcCtD
Milnacipran—Levomilnacipran—ABCB1—melanoma	0.00643	0.224	CrCbGaD
Milnacipran—Hot flush—Temozolomide—melanoma	0.00643	0.00662	CcSEcCtD
Milnacipran—Menopausal symptoms—Temozolomide—melanoma	0.00637	0.00656	CcSEcCtD
Milnacipran—Thirst—Temozolomide—melanoma	0.00632	0.00651	CcSEcCtD
Milnacipran—Hyponatraemia—Carmustine—melanoma	0.00625	0.00643	CcSEcCtD
Milnacipran—Chest discomfort—Docetaxel—melanoma	0.00623	0.00641	CcSEcCtD
Milnacipran—Liver function test abnormal—Dactinomycin—melanoma	0.00614	0.00632	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00599	0.00617	CcSEcCtD
Milnacipran—Infection—Vemurafenib—melanoma	0.00575	0.00592	CcSEcCtD
Milnacipran—Liver function test abnormal—Carmustine—melanoma	0.00575	0.00591	CcSEcCtD
Milnacipran—Nervous system disorder—Vemurafenib—melanoma	0.00567	0.00584	CcSEcCtD
Milnacipran—Skin disorder—Vemurafenib—melanoma	0.00562	0.00578	CcSEcCtD
Milnacipran—Weight decreased—Bleomycin—melanoma	0.00557	0.00574	CcSEcCtD
Milnacipran—Dry skin—Temozolomide—melanoma	0.00551	0.00567	CcSEcCtD
Milnacipran—Blood pressure increased—Docetaxel—melanoma	0.00551	0.00567	CcSEcCtD
Milnacipran—Breast disorder—Temozolomide—melanoma	0.00543	0.00559	CcSEcCtD
Milnacipran—Hypotension—Vemurafenib—melanoma	0.0054	0.00556	CcSEcCtD
Milnacipran—Neutropenia—Dactinomycin—melanoma	0.00537	0.00553	CcSEcCtD
Milnacipran—Haematuria—Bleomycin—melanoma	0.00524	0.00539	CcSEcCtD
Milnacipran—Abdominal distension—Temozolomide—melanoma	0.00523	0.00539	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00508	0.00523	CcSEcCtD
Milnacipran—Neutropenia—Carmustine—melanoma	0.00503	0.00518	CcSEcCtD
Milnacipran—Decreased appetite—Vemurafenib—melanoma	0.00503	0.00518	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Vemurafenib—melanoma	0.00499	0.00514	CcSEcCtD
Milnacipran—Fatigue—Vemurafenib—melanoma	0.00499	0.00513	CcSEcCtD
Milnacipran—Constipation—Vemurafenib—melanoma	0.00495	0.00509	CcSEcCtD
Milnacipran—Hypoaesthesia—Bleomycin—melanoma	0.00491	0.00505	CcSEcCtD
Milnacipran—Neutropenia—Temozolomide—melanoma	0.00486	0.005	CcSEcCtD
Milnacipran—Dysuria—Temozolomide—melanoma	0.00486	0.005	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Temozolomide—melanoma	0.00483	0.00497	CcSEcCtD
Milnacipran—Pollakiuria—Temozolomide—melanoma	0.0048	0.00494	CcSEcCtD
Milnacipran—Erectile dysfunction—Temozolomide—melanoma	0.00479	0.00493	CcSEcCtD
Milnacipran—Weight decreased—Temozolomide—melanoma	0.0047	0.00484	CcSEcCtD
Milnacipran—Urinary tract infection—Carmustine—melanoma	0.00466	0.0048	CcSEcCtD
Milnacipran—Hepatitis—Dactinomycin—melanoma	0.0046	0.00474	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00459	0.00473	CcSEcCtD
Milnacipran—Flushing—Bleomycin—melanoma	0.00458	0.00471	CcSEcCtD
Milnacipran—Body temperature increased—Vemurafenib—melanoma	0.00457	0.00471	CcSEcCtD
Milnacipran—Urinary tract infection—Temozolomide—melanoma	0.0045	0.00464	CcSEcCtD
Milnacipran—Chills—Bleomycin—melanoma	0.00443	0.00456	CcSEcCtD
Milnacipran—Hepatobiliary disease—Temozolomide—melanoma	0.00438	0.00451	CcSEcCtD
Milnacipran—Erythema multiforme—Dactinomycin—melanoma	0.00435	0.00448	CcSEcCtD
Milnacipran—Hypoaesthesia—Carmustine—melanoma	0.00428	0.00441	CcSEcCtD
Milnacipran—Hallucination—Carmustine—melanoma	0.00428	0.00441	CcSEcCtD
Milnacipran—Hot flush—Docetaxel—melanoma	0.00427	0.0044	CcSEcCtD
Milnacipran—Flushing—Dactinomycin—melanoma	0.00427	0.00439	CcSEcCtD
Milnacipran—Hypersensitivity—Vemurafenib—melanoma	0.00426	0.00439	CcSEcCtD
Milnacipran—Oedema peripheral—Carmustine—melanoma	0.00424	0.00437	CcSEcCtD
Milnacipran—Menopausal symptoms—Docetaxel—melanoma	0.00424	0.00436	CcSEcCtD
Milnacipran—Connective tissue disorder—Carmustine—melanoma	0.00423	0.00436	CcSEcCtD
Milnacipran—Hepatitis—Temozolomide—melanoma	0.00416	0.00428	CcSEcCtD
Milnacipran—Asthenia—Vemurafenib—melanoma	0.00415	0.00427	CcSEcCtD
Milnacipran—Hallucination—Temozolomide—melanoma	0.00414	0.00426	CcSEcCtD
Milnacipran—Hypoaesthesia—Temozolomide—melanoma	0.00414	0.00426	CcSEcCtD
Milnacipran—Chills—Dactinomycin—melanoma	0.00413	0.00425	CcSEcCtD
Milnacipran—Urinary tract disorder—Temozolomide—melanoma	0.00411	0.00423	CcSEcCtD
Milnacipran—Oedema peripheral—Temozolomide—melanoma	0.0041	0.00422	CcSEcCtD
Milnacipran—Pruritus—Vemurafenib—melanoma	0.00409	0.00421	CcSEcCtD
Milnacipran—Connective tissue disorder—Temozolomide—melanoma	0.00409	0.00421	CcSEcCtD
Milnacipran—Urethral disorder—Temozolomide—melanoma	0.00408	0.0042	CcSEcCtD
Milnacipran—Eye disorder—Carmustine—melanoma	0.00402	0.00414	CcSEcCtD
Milnacipran—Hyponatraemia—Docetaxel—melanoma	0.00402	0.00413	CcSEcCtD
Milnacipran—Flushing—Carmustine—melanoma	0.004	0.00411	CcSEcCtD
Milnacipran—Diarrhoea—Vemurafenib—melanoma	0.00396	0.00407	CcSEcCtD
Milnacipran—Migraine—Docetaxel—melanoma	0.00394	0.00405	CcSEcCtD
Milnacipran—Erythema multiforme—Temozolomide—melanoma	0.00393	0.00405	CcSEcCtD
Milnacipran—Eye disorder—Temozolomide—melanoma	0.00389	0.004	CcSEcCtD
Milnacipran—Flushing—Temozolomide—melanoma	0.00386	0.00398	CcSEcCtD
Milnacipran—Cardiac disorder—Temozolomide—melanoma	0.00386	0.00398	CcSEcCtD
Milnacipran—Leukopenia—Bleomycin—melanoma	0.00384	0.00396	CcSEcCtD
Milnacipran—Dizziness—Vemurafenib—melanoma	0.00382	0.00394	CcSEcCtD
Milnacipran—Angiopathy—Temozolomide—melanoma	0.00377	0.00389	CcSEcCtD
Milnacipran—Mental disorder—Carmustine—melanoma	0.00377	0.00388	CcSEcCtD
Milnacipran—Mediastinal disorder—Temozolomide—melanoma	0.00375	0.00386	CcSEcCtD
Milnacipran—Malnutrition—Carmustine—melanoma	0.00375	0.00386	CcSEcCtD
Milnacipran—Chills—Temozolomide—melanoma	0.00373	0.00384	CcSEcCtD
Milnacipran—Liver function test abnormal—Docetaxel—melanoma	0.00369	0.0038	CcSEcCtD
Milnacipran—Vomiting—Vemurafenib—melanoma	0.00368	0.00379	CcSEcCtD
Milnacipran—Dry skin—Docetaxel—melanoma	0.00367	0.00377	CcSEcCtD
Milnacipran—Chest pain—Bleomycin—melanoma	0.00366	0.00376	CcSEcCtD
Milnacipran—Rash—Vemurafenib—melanoma	0.00365	0.00375	CcSEcCtD
Milnacipran—Mental disorder—Temozolomide—melanoma	0.00364	0.00375	CcSEcCtD
Milnacipran—Dermatitis—Vemurafenib—melanoma	0.00364	0.00375	CcSEcCtD
Milnacipran—Headache—Vemurafenib—melanoma	0.00362	0.00373	CcSEcCtD
Milnacipran—Malnutrition—Temozolomide—melanoma	0.00362	0.00373	CcSEcCtD
Milnacipran—Breast disorder—Docetaxel—melanoma	0.00361	0.00372	CcSEcCtD
Milnacipran—Leukopenia—Dactinomycin—melanoma	0.00358	0.00369	CcSEcCtD
Milnacipran—Dysgeusia—Temozolomide—melanoma	0.00355	0.00365	CcSEcCtD
Milnacipran—Vision blurred—Carmustine—melanoma	0.00353	0.00364	CcSEcCtD
Milnacipran—Tremor—Carmustine—melanoma	0.00351	0.00361	CcSEcCtD
Milnacipran—Infection—Bleomycin—melanoma	0.00348	0.00358	CcSEcCtD
Milnacipran—Agitation—Carmustine—melanoma	0.00344	0.00355	CcSEcCtD
Milnacipran—Nausea—Vemurafenib—melanoma	0.00344	0.00354	CcSEcCtD
Milnacipran—Thrombocytopenia—Bleomycin—melanoma	0.00343	0.00353	CcSEcCtD
Milnacipran—Vision blurred—Temozolomide—melanoma	0.00341	0.00351	CcSEcCtD
Milnacipran—Tremor—Temozolomide—melanoma	0.00339	0.00349	CcSEcCtD
Milnacipran—Angina pectoris—Docetaxel—melanoma	0.00337	0.00347	CcSEcCtD
Milnacipran—Leukopenia—Carmustine—melanoma	0.00335	0.00345	CcSEcCtD
Milnacipran—Anorexia—Bleomycin—melanoma	0.00334	0.00344	CcSEcCtD
Milnacipran—Agitation—Temozolomide—melanoma	0.00333	0.00343	CcSEcCtD
Milnacipran—Hypotension—Bleomycin—melanoma	0.00327	0.00337	CcSEcCtD
Milnacipran—Convulsion—Carmustine—melanoma	0.00325	0.00334	CcSEcCtD
Milnacipran—Infection—Dactinomycin—melanoma	0.00325	0.00334	CcSEcCtD
Milnacipran—Leukopenia—Temozolomide—melanoma	0.00324	0.00334	CcSEcCtD
Milnacipran—Hypertension—Carmustine—melanoma	0.00324	0.00333	CcSEcCtD
Milnacipran—Neutropenia—Docetaxel—melanoma	0.00323	0.00333	CcSEcCtD
Milnacipran—Palpitations—Temozolomide—melanoma	0.0032	0.00329	CcSEcCtD
Milnacipran—Thrombocytopenia—Dactinomycin—melanoma	0.0032	0.00329	CcSEcCtD
Milnacipran—Chest pain—Carmustine—melanoma	0.00319	0.00328	CcSEcCtD
Milnacipran—Anxiety—Carmustine—melanoma	0.00318	0.00327	CcSEcCtD
Milnacipran—Paraesthesia—Bleomycin—melanoma	0.00315	0.00324	CcSEcCtD
Milnacipran—Convulsion—Temozolomide—melanoma	0.00314	0.00323	CcSEcCtD
Milnacipran—Weight decreased—Docetaxel—melanoma	0.00313	0.00322	CcSEcCtD
Milnacipran—Hypertension—Temozolomide—melanoma	0.00313	0.00322	CcSEcCtD
Milnacipran—Dyspnoea—Bleomycin—melanoma	0.00312	0.00322	CcSEcCtD
Milnacipran—Anorexia—Dactinomycin—melanoma	0.00311	0.00321	CcSEcCtD
Milnacipran—Anxiety—Temozolomide—melanoma	0.00307	0.00316	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00306	0.00315	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00306	0.00315	CcSEcCtD
Milnacipran—Decreased appetite—Bleomycin—melanoma	0.00305	0.00314	CcSEcCtD
Milnacipran—Infection—Carmustine—melanoma	0.00304	0.00313	CcSEcCtD
Milnacipran—Pethidine—ALB—melanoma	0.00304	0.106	CrCbGaD
Milnacipran—Dry mouth—Temozolomide—melanoma	0.00302	0.0031	CcSEcCtD
Milnacipran—Thrombocytopenia—Carmustine—melanoma	0.00299	0.00308	CcSEcCtD
Milnacipran—Tachycardia—Carmustine—melanoma	0.00298	0.00307	CcSEcCtD
Milnacipran—Infection—Temozolomide—melanoma	0.00294	0.00302	CcSEcCtD
Milnacipran—Anorexia—Carmustine—melanoma	0.00292	0.003	CcSEcCtD
Milnacipran—Hepatobiliary disease—Docetaxel—melanoma	0.00291	0.003	CcSEcCtD
Milnacipran—Nervous system disorder—Temozolomide—melanoma	0.0029	0.00298	CcSEcCtD
Milnacipran—Thrombocytopenia—Temozolomide—melanoma	0.00289	0.00298	CcSEcCtD
Milnacipran—Skin disorder—Temozolomide—melanoma	0.00287	0.00296	CcSEcCtD
Milnacipran—Hypotension—Carmustine—melanoma	0.00286	0.00294	CcSEcCtD
Milnacipran—Hyperhidrosis—Temozolomide—melanoma	0.00286	0.00294	CcSEcCtD
Milnacipran—Decreased appetite—Dactinomycin—melanoma	0.00284	0.00292	CcSEcCtD
Milnacipran—Fatigue—Dactinomycin—melanoma	0.00282	0.0029	CcSEcCtD
Milnacipran—Anorexia—Temozolomide—melanoma	0.00282	0.0029	CcSEcCtD
Milnacipran—Urticaria—Bleomycin—melanoma	0.00278	0.00287	CcSEcCtD
Milnacipran—Body temperature increased—Bleomycin—melanoma	0.00277	0.00285	CcSEcCtD
Milnacipran—Hepatitis—Docetaxel—melanoma	0.00277	0.00285	CcSEcCtD
Milnacipran—Insomnia—Carmustine—melanoma	0.00277	0.00285	CcSEcCtD
Milnacipran—Hypoaesthesia—Docetaxel—melanoma	0.00275	0.00283	CcSEcCtD
Milnacipran—Paraesthesia—Carmustine—melanoma	0.00275	0.00283	CcSEcCtD
Milnacipran—Urinary tract disorder—Docetaxel—melanoma	0.00273	0.00281	CcSEcCtD
Milnacipran—Dyspnoea—Carmustine—melanoma	0.00273	0.00281	CcSEcCtD
Milnacipran—Oedema peripheral—Docetaxel—melanoma	0.00273	0.00281	CcSEcCtD
Milnacipran—Somnolence—Carmustine—melanoma	0.00272	0.0028	CcSEcCtD
Milnacipran—Connective tissue disorder—Docetaxel—melanoma	0.00272	0.0028	CcSEcCtD
Milnacipran—Urethral disorder—Docetaxel—melanoma	0.00271	0.00279	CcSEcCtD
Milnacipran—Insomnia—Temozolomide—melanoma	0.00267	0.00275	CcSEcCtD
Milnacipran—Gastrointestinal pain—Dactinomycin—melanoma	0.00267	0.00275	CcSEcCtD
Milnacipran—Decreased appetite—Carmustine—melanoma	0.00266	0.00274	CcSEcCtD
Milnacipran—Paraesthesia—Temozolomide—melanoma	0.00265	0.00273	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Carmustine—melanoma	0.00264	0.00272	CcSEcCtD
Milnacipran—Dyspnoea—Temozolomide—melanoma	0.00264	0.00271	CcSEcCtD
Milnacipran—Somnolence—Temozolomide—melanoma	0.00263	0.00271	CcSEcCtD
Milnacipran—Erythema multiforme—Docetaxel—melanoma	0.00262	0.00269	CcSEcCtD
Milnacipran—Constipation—Carmustine—melanoma	0.00262	0.00269	CcSEcCtD
Milnacipran—Dyspepsia—Temozolomide—melanoma	0.0026	0.00268	CcSEcCtD
Milnacipran—Eye disorder—Docetaxel—melanoma	0.00259	0.00266	CcSEcCtD
Milnacipran—Body temperature increased—Dactinomycin—melanoma	0.00258	0.00266	CcSEcCtD
Milnacipran—Abdominal pain—Dactinomycin—melanoma	0.00258	0.00266	CcSEcCtD
Milnacipran—Hypersensitivity—Bleomycin—melanoma	0.00258	0.00266	CcSEcCtD
Milnacipran—Decreased appetite—Temozolomide—melanoma	0.00257	0.00265	CcSEcCtD
Milnacipran—Cardiac disorder—Docetaxel—melanoma	0.00257	0.00264	CcSEcCtD
Milnacipran—Flushing—Docetaxel—melanoma	0.00257	0.00264	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Temozolomide—melanoma	0.00255	0.00263	CcSEcCtD
Milnacipran—Fatigue—Temozolomide—melanoma	0.00255	0.00262	CcSEcCtD
Milnacipran—Constipation—Temozolomide—melanoma	0.00253	0.0026	CcSEcCtD
Milnacipran—Asthenia—Bleomycin—melanoma	0.00251	0.00259	CcSEcCtD
Milnacipran—Angiopathy—Docetaxel—melanoma	0.00251	0.00258	CcSEcCtD
Milnacipran—Gastrointestinal pain—Carmustine—melanoma	0.0025	0.00257	CcSEcCtD
Milnacipran—Mediastinal disorder—Docetaxel—melanoma	0.00249	0.00257	CcSEcCtD
Milnacipran—Chills—Docetaxel—melanoma	0.00248	0.00256	CcSEcCtD
Milnacipran—Pruritus—Bleomycin—melanoma	0.00248	0.00255	CcSEcCtD
Milnacipran—Mental disorder—Docetaxel—melanoma	0.00242	0.0025	CcSEcCtD
Milnacipran—Body temperature increased—Carmustine—melanoma	0.00242	0.00249	CcSEcCtD
Milnacipran—Abdominal pain—Carmustine—melanoma	0.00242	0.00249	CcSEcCtD
Milnacipran—Gastrointestinal pain—Temozolomide—melanoma	0.00242	0.00249	CcSEcCtD
Milnacipran—Malnutrition—Docetaxel—melanoma	0.00241	0.00248	CcSEcCtD
Milnacipran—Hypersensitivity—Dactinomycin—melanoma	0.00241	0.00248	CcSEcCtD
Milnacipran—Dysgeusia—Docetaxel—melanoma	0.00236	0.00243	CcSEcCtD
Milnacipran—Urticaria—Temozolomide—melanoma	0.00235	0.00242	CcSEcCtD
Milnacipran—Asthenia—Dactinomycin—melanoma	0.00234	0.00241	CcSEcCtD
Milnacipran—Body temperature increased—Temozolomide—melanoma	0.00234	0.00241	CcSEcCtD
Milnacipran—Abdominal pain—Temozolomide—melanoma	0.00234	0.00241	CcSEcCtD
Milnacipran—Hypersensitivity—Carmustine—melanoma	0.00225	0.00232	CcSEcCtD
Milnacipran—Diarrhoea—Dactinomycin—melanoma	0.00224	0.0023	CcSEcCtD
Milnacipran—Vomiting—Bleomycin—melanoma	0.00223	0.00229	CcSEcCtD
Milnacipran—Rash—Bleomycin—melanoma	0.00221	0.00227	CcSEcCtD
Milnacipran—Dermatitis—Bleomycin—melanoma	0.00221	0.00227	CcSEcCtD
Milnacipran—Asthenia—Carmustine—melanoma	0.00219	0.00226	CcSEcCtD
Milnacipran—Hypersensitivity—Temozolomide—melanoma	0.00218	0.00224	CcSEcCtD
Milnacipran—Syncope—Docetaxel—melanoma	0.00216	0.00222	CcSEcCtD
Milnacipran—Leukopenia—Docetaxel—melanoma	0.00216	0.00222	CcSEcCtD
Milnacipran—Palpitations—Docetaxel—melanoma	0.00213	0.00219	CcSEcCtD
Milnacipran—Asthenia—Temozolomide—melanoma	0.00212	0.00218	CcSEcCtD
Milnacipran—Loss of consciousness—Docetaxel—melanoma	0.00212	0.00218	CcSEcCtD
Milnacipran—Diarrhoea—Carmustine—melanoma	0.00209	0.00215	CcSEcCtD
Milnacipran—Pruritus—Temozolomide—melanoma	0.00209	0.00215	CcSEcCtD
Milnacipran—Convulsion—Docetaxel—melanoma	0.00209	0.00215	CcSEcCtD
Milnacipran—Nausea—Bleomycin—melanoma	0.00208	0.00214	CcSEcCtD
Milnacipran—Hypertension—Docetaxel—melanoma	0.00208	0.00214	CcSEcCtD
Milnacipran—Vomiting—Dactinomycin—melanoma	0.00208	0.00214	CcSEcCtD
Milnacipran—Rash—Dactinomycin—melanoma	0.00206	0.00212	CcSEcCtD
Milnacipran—Chest pain—Docetaxel—melanoma	0.00205	0.00211	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00204	0.0021	CcSEcCtD
Milnacipran—Dizziness—Carmustine—melanoma	0.00202	0.00208	CcSEcCtD
Milnacipran—Diarrhoea—Temozolomide—melanoma	0.00202	0.00208	CcSEcCtD
Milnacipran—Dry mouth—Docetaxel—melanoma	0.00201	0.00206	CcSEcCtD
Milnacipran—Dizziness—Temozolomide—melanoma	0.00195	0.00201	CcSEcCtD
Milnacipran—Infection—Docetaxel—melanoma	0.00195	0.00201	CcSEcCtD
Milnacipran—Vomiting—Carmustine—melanoma	0.00194	0.002	CcSEcCtD
Milnacipran—Nausea—Dactinomycin—melanoma	0.00194	0.002	CcSEcCtD
Milnacipran—Shock—Docetaxel—melanoma	0.00193	0.00199	CcSEcCtD
Milnacipran—Rash—Carmustine—melanoma	0.00193	0.00199	CcSEcCtD
Milnacipran—Nervous system disorder—Docetaxel—melanoma	0.00193	0.00198	CcSEcCtD
Milnacipran—Dermatitis—Carmustine—melanoma	0.00193	0.00198	CcSEcCtD
Milnacipran—Thrombocytopenia—Docetaxel—melanoma	0.00192	0.00198	CcSEcCtD
Milnacipran—Tachycardia—Docetaxel—melanoma	0.00192	0.00197	CcSEcCtD
Milnacipran—Headache—Carmustine—melanoma	0.00192	0.00197	CcSEcCtD
Milnacipran—Skin disorder—Docetaxel—melanoma	0.00191	0.00197	CcSEcCtD
Milnacipran—Vomiting—Temozolomide—melanoma	0.00188	0.00193	CcSEcCtD
Milnacipran—Anorexia—Docetaxel—melanoma	0.00187	0.00193	CcSEcCtD
Milnacipran—Rash—Temozolomide—melanoma	0.00186	0.00192	CcSEcCtD
Milnacipran—Dermatitis—Temozolomide—melanoma	0.00186	0.00192	CcSEcCtD
Milnacipran—Headache—Temozolomide—melanoma	0.00185	0.00191	CcSEcCtD
Milnacipran—Hypotension—Docetaxel—melanoma	0.00184	0.00189	CcSEcCtD
Milnacipran—Nausea—Carmustine—melanoma	0.00182	0.00187	CcSEcCtD
Milnacipran—Insomnia—Docetaxel—melanoma	0.00178	0.00183	CcSEcCtD
Milnacipran—Paraesthesia—Docetaxel—melanoma	0.00176	0.00182	CcSEcCtD
Milnacipran—Nausea—Temozolomide—melanoma	0.00176	0.00181	CcSEcCtD
Milnacipran—Dyspnoea—Docetaxel—melanoma	0.00175	0.0018	CcSEcCtD
Milnacipran—Somnolence—Docetaxel—melanoma	0.00175	0.0018	CcSEcCtD
Milnacipran—Dyspepsia—Docetaxel—melanoma	0.00173	0.00178	CcSEcCtD
Milnacipran—Decreased appetite—Docetaxel—melanoma	0.00171	0.00176	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Docetaxel—melanoma	0.0017	0.00175	CcSEcCtD
Milnacipran—Fatigue—Docetaxel—melanoma	0.00169	0.00174	CcSEcCtD
Milnacipran—Constipation—Docetaxel—melanoma	0.00168	0.00173	CcSEcCtD
Milnacipran—Gastrointestinal pain—Docetaxel—melanoma	0.00161	0.00165	CcSEcCtD
Milnacipran—Abdominal pain—Docetaxel—melanoma	0.00155	0.0016	CcSEcCtD
Milnacipran—Body temperature increased—Docetaxel—melanoma	0.00155	0.0016	CcSEcCtD
Milnacipran—Hypersensitivity—Docetaxel—melanoma	0.00145	0.00149	CcSEcCtD
Milnacipran—Asthenia—Docetaxel—melanoma	0.00141	0.00145	CcSEcCtD
Milnacipran—Pruritus—Docetaxel—melanoma	0.00139	0.00143	CcSEcCtD
Milnacipran—Diarrhoea—Docetaxel—melanoma	0.00134	0.00138	CcSEcCtD
Milnacipran—Dizziness—Docetaxel—melanoma	0.0013	0.00134	CcSEcCtD
Milnacipran—Vomiting—Docetaxel—melanoma	0.00125	0.00129	CcSEcCtD
Milnacipran—Rash—Docetaxel—melanoma	0.00124	0.00128	CcSEcCtD
Milnacipran—Dermatitis—Docetaxel—melanoma	0.00124	0.00127	CcSEcCtD
Milnacipran—Headache—Docetaxel—melanoma	0.00123	0.00127	CcSEcCtD
Milnacipran—Nausea—Docetaxel—melanoma	0.00117	0.0012	CcSEcCtD
